Pharmacoeconomics,
Epidemiology,
Pharmaceutical
Policy and
Outcomes
Research (PEPPOR)
Graduate Program
Back Row (right to Left): Akshay Kharat PhD Student, Vishvas Garg PhD
Candidate, Professor Dennis Raisch, Associate Professor Matthew Borrego,
Associate Professor Ludmila Bakhireva, Master's Student Renee Donohoe,
Master's Student Alex Woersching; Front row: Ghadeer Dawwas PhD Student,
Rasha Arabyat PhD Student, Melissa Roberts PhD Candidate, Mahek Garg
Master's Student, Khalid Al Moaikel PhD Student; Not Pictured: Ning Yan Gu
Assistant Professor, Luis Robles PhD Student, Yuebin Zhao PhD student
Scholarship
click HERE for a listing of our Grants & Awards
Faculty Publications: | M.Sather | D. Raisch | N. Khan | M. Borrego | L. Bakhireva |
Student Publications & Presentations: | V. Bali | H. Campbell | R. Naik | R. Ringer |
Ludmila Bakhireva, MD, PhD, MPH
Kuperman B, Matey V, Fisher R, Ervin E, Warburton M, Bakhireva L, Lehman C. Parasites of the African clawed frog, Xenopus laevis, in Southern California. Journal of Comparative Parasitology. 2003:71:229-232.
Bakhireva LN, Abebe Y, Brodine S, Kraft H, Shaffer R, Boyer C. HIV/AIDS Knowledge and Risk Factors in Ethiopian Military Personnel. Mil Med. 2004; 169(3):221-6.
Bakhireva LN, Barrett-Connor E, Kritz-Silverstein D, Morton D. Modifiable Predictors of Bone Loss in Older Men: The Rancho Bernardo Study. Am J Prev Med. 2004;26(5):436-42.
Bakhireva LN, Barrett-Connor EL, Laughlin GA, Kritz-Silverstein D. Differences in association of bone mineral density with coronary calcification in men and women: the Rancho Bernardo Study. Menopause. 2005; 12(6): 691-8.
Bakhireva LN, Jones KL, Schatz M, Johnson D, Chambers CD, The Organization Of Teratology Information Services Research Group. Asthma medication use in pregnancy and fetal growth. J Allergy Clin Immunol. 2005;116(3):503-9.
Chambers CC, Kavteladze L, Joutchenko L, Bakhireva LN, Jones KL. Alcohol consumption patterns among pregnant women in the Moscow region of the Russian Federation. Alcohol. 2006;38(3):133-7.
Jones KL, Robinson LK, Bakhireva LN, Marintcheva G, Storojev V, Strahova A, Sergeevskaya S, Budantseva S, Mattson SN, Riley EP, Chambers CD. Accuracy of the diagnosis of physical features of fetal alcohol syndrome by pediatricians after specialized training. Pediatrics. 2006;118(6):1734-8.
Arenson A.D., Bakhireva L., Chambers T., Deximo C., Foroud T., Jacobson J., Jacobson S., Jones K.L., Mattson S., May P., Moore E., Ogle K., Riley E., Robinson L., Rogers J., Streissguth A., Tavares M., Urbanski J., Yezerets H., Stewart C.A. Implementation of a Distributed Architecture for Managing Collection and Dissemination of Data for Fetal Alcohol Spectrum Disorders Research. Lecture Notes in Computer Science. 2007: 4360:33-44.
Bakhireva LN, Schatz M, Chambers CD. Effect of Maternal Asthma and Gestational Asthma Therapy on Fetal Growth. Review Article. Journal of Asthma. 2007; 44(2):71-76.
Bakhireva LN, Jones KL, Schatz M, Klonoff-Cohen H, Johnson D, Slymen D, Chambers CD, The Organization Of Teratology Information Services Research Group. Safety of Leukotriene Receptor Antagonists in Pregnancy. J Allergy Clin Immunol . 2007:199(3):618-25.
Bakhireva LN, Schatz M, Jones KL, Tucker CM, Slymen DJ, Klonoff-Cohen HS, Gresham L, Johnson D, Chambers CD, OTIS Collaborative Research Group. Fetal Sex and Maternal Asthma Control in Pregnancy. J Asthma. 2008; 45:403-7.
Bakhireva LN, Laughlin GA, Bettencourt, R, Barrett-Connor E. Does Osteoprotegerin or RANKL Medicate the Association Between Bone and Coronary Artery Calcification? J Clin Endocrin Metab. 2008; 93(5):2009-12.
Bakhireva LN, Schatz M, Jones KL, Chambers CD, OTIS Collaborative Research Group. Asthma Control During Pregnancy and the Risk of Preterm Delivery or Impaired Fetal Growth. Ann Allergy Asthma Immunol. 2008;101:137-43
Jones KL, Hoyme HE, Robinson LK, Del Campo M, Manning MA, Bakhireva LN, Prewitt LM, Chambers CD. Developmental pathogenesis of short palpebral fissue length in children with fetal alcohol syndrome. Birth Defects Res A Clin Mol Teratol. 2009 Apr 6. [Epub ahead of print]
Kfir M, Yevtushok L, Onishchenko S, Wertelecki W, Bakhireva LN, Chambers CD, Jones KL, Hull AD. Can Prenatal Ultrasound Detect the Effects of in utero Alcohol Exposure? A pilot study. Ultrasound Obstet Gynecol. 2009 in press.
BE Benson, DA Spyker, WG Troutman, WA Watson, LN Bakhireva. Amlodipine Toxicity in Children Less than 6 Years of Age: A Dose-response Analysis Using National Poison Data System (NPDS) Data. The Journal of Emergency Medicine. 2009 in press.
Matthew Borrego, PhD
Borrego ME, Rhyne R, Hansbarger L, Geller Z, Edwards P, Griffin B, McClain L, Scaletti JV. Pharmacy Student Participation in Rural Interdisciplinary Education Using Problem Based Learning (PBL) Case Tutorials. American Journal of Pharmaceutical Education. 2000:64, 355-363 (Winter).
Marshik PL,
Borrego ME, Baldonado EM, Baur KL, Cipa GH, George III LC. New Mexico
Public School Practices Regarding Use and Administration of Asthma
Medications. Pediatric Asthma, Allergy & Immunology. 2001:15 (1), 31-41.
Slack MK, Cummings DM, Borrego ME, Fuller K, Cook S. "Strategies used by interdisciplinary rural health training programs to assure community responsiveness and recruit practitioners". Journal of Interprofessional Care. 2002;16(2), 129-138.
Geller Z, Rhyne R, Hansbarger C, Borrego M, VanLeit B, Scaletti J. Interdisciplinary health professional education in rural New Mexico: a 10 year experience. Learning in Health and Social Care. 2002:1(1)33-46.
Burden RW, Kumar RN, Phillips D, Borrego ME, Galloway JM. Hyperlipidemia in Native Americans: Evaluation of Lipid Management through a Cardiovascular Risk Reduction Program. Journal of the American Pharmaceutical Association.2002;42:652-5.
Kumar RN, Raisch DW, Borrego ME. Quality Assessment of Economic Analyses of Pharmacologic and Nutritional Therapy for Lipid Disorders. Expert Review of Pharmacoeconomics and Outcomes Research. 2002: 2: (6) 89-99.
Gupchup GV, Borrego ME, Khonduri N. The Impact of Student Life Stress on Health Related Quality of Life Among Doctor of Pharmacy Students. College Student Journal. 2004: 38 (2): 292-301
Dominguez KD, Borrego ME. Bowel Frequency in Critically Ill Children. Journal of Pediatric Pharmacology and Therapeutics. 2005;9:187-191.
Gupchup GV, Borrego ME, Santos R, Shah B. Economic and Patient Preference Considerations for Intranasal Corticosteroids in Allergic Rhinitis: Implications for Managed Care. Disease Management & Health Outcomes. 2005:13 (3):169-184.
Borrego M, Short J, House N, Gupchup G, Naik R, Cuellar D. New Mexico Pharmacists’ Knowledge, Attitudes, and Beliefs Toward Prescribing Oral Emergency Contraception. J Am Pharm Assoc. 2006;46:33-43.
Konduri N, Gupchup GV, Borrego ME, Worley-Louis M. Assessment of the Reliability And Validity of a Stress Questionnaire for Pharmacy Administration Graduate Students. College Student Journal. 2006;40(1):78-90.
Meissner B, Harrison D, Carter J, Borrego M. Predicting the impact of Medicare Part D implementation on the pharmacy workforce. Research in Social and Administrative Pharmacy. 2006;2:315-328.
Jakiche R, Borrego M, Raisch D, Gupchup G, Pai M, Jakiche A. The cost-effectiveness of two strategies for vaccinating US Veterans with Hepatitis C virus infection against Hepatitis A and Hepatitis B in the US. American Journal of the Medical Sciences.2007:333(1):26-34.
Naik R, Borrego M, Gupchup G, Dodd M, Sather M. Pharmacy Students' Knowledge, Attitudes and Evaluation of Direct-to-Consumer Advertising. American Journal of Pharmaceutical Education. 2007; 71 (5) Article 86:1-10.
Shah BM, Gupchup GV, Borrego ME, Raisch DW, Knapp K. Depressive Symptoms in Patients with Type 2 Diabetes Mellitus in the Ambulatory Care Setting: Opportunities to Improve Outcomes in the Course of Routine Care. Journal of the American Pharmacists Association.2008; 48(6):737-43
Nasreen Khan, PhD
Peer-Reviewed Publications
Khan N, Dollimore D, Alexander K. The origin of exothermic peak in the thermal decomposition of Magnesium carbonate. Thermochemica Acta 2001; 367-368:321-33.
Zwanziger J, Khan N. Strategic factors in hospital selection for HMO and PPO provider networks. Medical Care Research Review 2006; 63 90S-111S.
Zwanziger J, Khan N. Identifying safety net hospitals. Medical Care Research Review 2008; 65:478-95.
Khan N, Kaestner R, Lin S-J. Effect of Prescription Drug Coverage on Health of the Elderly. Health Services Research 2008; 43:1576-97
Khan N, Kaestner R. Effect of Prescription Drug Coverage on Elderly Use of Prescription Drugs. Inquiry. 2009; 46(1): 33-45.
Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Pharmaceutical Care Is Associated With Reduced Medication Utilization And Hospitalization Rates In Hemodialysis (Hd) Patients-A 2 Year Randomized, Controlled Study. Pharmacotherapy. In press.
Other Publications
Khan N, Kaestner R. The effect of Prescription drug insurance on utilization and health among the elderly. National Bureau of Economic Research 2006; Working paper Series # 12848.
Khan N, Kaestner R, Lin S-J. The effect of Prescription drug insurance on utilization and health among the elderly. National Bureau of Economic Research Bulletin on Aging and Health Winter 2007; 18.
Khan N, Kaestner R, Lin S-J. The effect of Prescription drug insurance on utilization and health among the elderly. New Mexico Prescription Improvement Coalition June 2007; Vol 2 (6).
Dennis W. Raisch, PhD
Peer Reviewed Publications
Raisch DW, Johnson KT, Roth C. Evaluation of piggyback administration sets. Am J Hosp Pharm 1977; 34:1315 23.
McGhan WF, Larson LN, Raisch DW. The effects of DRGs and cost containment: assessment of hospital pharmacy directors. Hosp Form 1986; 21:870 6.
Larson LN, Bootman JL, McGhan WF, Raisch DW. Community pharmacy in Arizona's prepaid Medicaid program. Am Pharm 1986; NS26:780 4.
Raisch DW, Bootman JL, McGhan WF. Association of length of stay and
total hospital charges with antimicrobial regimen changes. Am J Hosp
Pharm 1988; 45:819 23.
Raisch DW, Larson LN, Bootman JL. Pharmacy policies in the Arizona prepaid Medicaid program. Am J Hosp Pharm 1988; 45: 1113 5.
Raisch DW, Bootman JL, McGhan WF, Sabers DL, Messier DR. Evaluating length of stay and charge differences between antibiotic regimens within selected DRGs. Topics Hosp Pharm Mgmt 1988; 8(1):13 24.
Raisch DW, Larson LN, Bootman JL. Pharmacy participation in third party contracts: Decision making through economic and financial analysis. J Pharm Market Manage 1989; 3(4):37 49.
Raisch DW. A model of methods for influencing prescribing: Part I. A review of prescribing models, persuasion theo¬ries, and administrative and educational methods. DICP Ann Pharmacother 1990;24:417 21.
Raisch DW. A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model. DICP Ann Pharmacother 1990;24:537 42.
Raisch DW, Bootman JL, Larson LN, McGhan WF. Improving antiulcer agent prescribing in a health maintenance organization. Am J Hosp Pharm 1990; 47:1766 73.
Raisch DW, Barreuther AD, Osborne RC. Evaluation of a Non FDA approved use of cimetidine Treatment of pruritus resulting from epidural morphine analgesia. DICP Ann Pharmacother 1991; 25:716 718.
Holdsworth MT, Raisch DW. Availability of narcotics and pharmacist attitudes toward narcotic prescriptions for cancer patients. Ann Pharmacother 1992; 26:321 6.
Raisch DW. Relationships among prescription payment methods and interactions between community pharmacists and prescribers. Ann Pharmacother 1992; 26:902 6.
Holdsworth MT, Raisch DW. Perceptions of pharmacy students concerning cancer pain and its treatment. Am J Pharm Educ 1993; 57:29 35.
Raisch DW. Interactions between pharmacists and prescribers in community pharmacies: Differences between practice sites. J Soc Admin Pharm 1993; 10(1): 42-51.
Raisch DW. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings. Ann Pharmacother 1993; 27:1173-79.
Raisch DW. Barriers to providing cognitive services. Am Pharm 1993; NS33(12): 55-58.
Raisch DW, Holdsworth MT, Herring D, Kuhl DE. Development and qualitative evaluation of rural ambulatory care clinical clerkship. Am J Pharm Educ 1993; 57: 333-9.
Holdsworth MT, Raisch DW, Duncan, MH, Chavez CM, Leasure MM. Assessment of chemotherapy induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. Ann Pharmacother 1995;29:16-21.
Raisch DW, Holdsworth MT, Mann PL, Kabat HF. Incorporating problem-based, student-centered learning into pharmacy externship rotations. Am J Pharm Educ 1995; 59:265-72.
Holdsworth MT, Raisch DW, Chavez CM, Duncan MH, Parasuranan TV, Cox FM. Economic impact with home delivery of chemotherapy to pediatric oncology patients. Ann Pharmacother 1997; 31:140-147.
Holdsworth MT, Raisch DW, Winter SS, Chavez CM, Leasure MM, Duncan MH. Procedure-related pain in children with cancer: Examination of differences among raters and evaluation of the success of EMLA Cream with repeated painful procedures. Pharmacotherapy 1997; 17(5):1017-22.
Holdsworth MT, Raisch DW, Winter SS, Chavez CM. Assessment of the emetogenic potential of intrathecal chemotherapy and evaluation of the efficacy of ondansetron in the prevention of nausea/vomiting from intrathecal chemotherapy. Supportive Care in Cancer 1998; 6:132-8.
Raisch DW, Hammond RW, Hollarbush JL, Wood M. Evaluation of a pharmacist-focused educational intervention for decreasing ketorolac use in a Medicaid program. Am J Health-Syst Pharm 1998;55:1274-80.
Jones MS, Raisch DW, Garnand DA, Sather MR. The use of a remote computerized system for study data documentation in clinical trials. Drug Information Journal 1998;32:1153-63.
Raisch DW, Sleath BS. Influencing the use of anti-ulcer agents in a Medicaid program through patient-specific prescribing feedback letters. J Gen Intern Med 1999;14:145-150.
Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, Raisch D, Caligiuri M, Tracy K, and the Veterans Affairs Cooperative Study #394 Study Group. Vitamin E for tardive dyskinesia. Arch Gen Psychiatry 1999;56:836-841.
Singhal PK, Raisch DW, Gupchup GV. The impact of pharmacists’ interventions in the community and other ambulatory care settings: research evidence and recommendations for future research. Ann Pharmacother 1999; 33:1336-1355.
Bennett CL, Davidson CJ, Raisch DW, Weinberg PD, Bennett RH, Feldman MD. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of cardiac artery stents and stroke prevention. Arch Intern Med 1999; 159:2524-28.
Small BE, Holdsworth MT, Raisch DW, Winter SS. Survey ranking of emetogenic control in children receiving chemotherapy. J Pediatr Hematol Oncol 2000; 22(2):125-32.
Raisch DW. Understanding adjusted life
years (QALYs) and their application to pharmacoeconomic research. Ann
Pharmacother 2000; 34(7/8):906-14.
Holdsworth MT, Adams V,
Raisch DW, Wood JG, Winter SS. Computerized system for outcomes-based antiemetic therapy in children. Ann Pharmacother 2000;34(10):1101-8.
Raisch DW, Klaurens LM, Hayden C, Malagon I, Pulliam G, Fass R. Health care utilization costs and outcomes associated with a formulary change in proton pump inhibitors. Digestive Diseases and Sciences 2001;46:1533-39.
Mathew P, Suarez W, Kip K, Bayar E, Jasty R, Matloub Y, Raisch D. Is there a potential role for serum cardiac troponin I as a marker for myocardial dysfunction in pediatric patients receiving anthracycline-based therapy? A pilot study. Cancer Investigation 2001;19(4):352-59.
Raisch DW, Troutman WG, Sather MR, Fudala PJ. Variability in assessment of adverse medical events in a multicenter clinical trial. Clinical Therapeutics 200l;23:2011-20.
Raisch DW, Fye CL, Boardman K, Sather MR.
Opioid dependence treatment, including buprenorphine/naloxone. Ann
Pharmacother 2002; 36:312-21.
Singhal PK, Gupchup GV,
Raisch DW, Schommer JC, Holdsworth MT. Impact of pharmacists’ directive guidance behaviors on patient satisfaction. J Am Pharm Assoc 2002;42:407-12.
Kumar RN, Raisch DW, Borrego ME. Review and quality assessment of the literature reporting the economic analyses of pharmacologic and nutritional therapy for lipid disorders. Expert Rev Pharmacoeconomics Outcomes Res 2002;2(6):89-99.
Bennett CL, Schumock GT, Desai AA, Kwaan HC, Raisch DW, Newlin R, Stadler W. Thalidomide-associated deep vein thrombosis and pulmonary embolism. Am J Med 2002; 113:603-6.
Raisch DW, Holdsworth MT, Winter SS, Hutter J, Graham ML. Home versus hospital treatment of febrile neutropenia in children: Comparison of healthcare resource utilization. Value in Health 2003:6:158-166.
Holdsworth MT, Raisch DW, Winter SS, Frost JD, Moro MA, Doran NH, Phillips J, Pankey JM, Mathew P. Pain and distress from bone marrow aspirations and lumbar punctures. Ann Pharmacother 2003;37:17-22.
Holdsworth MT, Fichtl RE, Behta M, Raisch DW, Mendez-Rico E, Adams A, Greifer M, Bostwick S, Greenwald BM. Incidence of adverse drug events in pediatric patients. Arch Pedatr Adoles Med 2003;157:60-65.
Raisch DW, Netravali S, Harris CL. Pharmacoeconomic implications of large multi-center clinical trials. Ann Pharmacother 2003; 37:447-50.
Fudala PJ , Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch DW, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New Engl J Med 2003;349:949-58.
Sather MR, Raisch DW, Haakenson CL, Buckelew JM, Feussner JR. Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies Program. Cont Clin Trial 2003;24:570-84.
Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL. Dissemination of Information on potentially fatal adverse drug reactions for cancer drugs from 2000-2002: First results from the research on adverse drug events and reports projects. J Clin Oncol 2003;21:3859-3866.
Fye CL Gagne WH, Raisch DW, Jones MS, Sather MR, Buchanan SL, Chacon FR, Garg R, Yusuf S, Williford WO. The role of the pharmacy coordinating center in the DIG trial. Cont Clin Trials 2003;24:289S-297S.
Gupchup GV, Marfatia AA, Bartley M, Bennett B, Worley-Louis MM, Raisch DW, Dole EJ. Intention to use herbal medicines among older outpatients. J Soc Admin Pharm 2003; 20(6):249-256.
Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch D, Kim B, Kwaan H, McKoy J, Schmitt B, Davidson C, Yarnold PR, Gorelick P, Bennett C. Clopidogrel-associated TTP:an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke 2004; 35:533-7.
Kumar RN, Gupchup GV, Dodd MA, Michael Iskedjian M, Einarson TR, Raisch DW. Health care costs associated with four categories of skin ulcers in New Mexico Medicaid fee-for-service patients. Adv Skin Wound Care 2004;17:143-9.
Bennett CL, Luminari S, Nissenson AR,
Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio
S, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F,
Rossert J, Casadevall N. Pure red-cell aplasia and epoetin therapy. N
Engl J Med 2004;351:1403-8.
Raisch DW, Holdsworth MT, Marshik PL, Campbell HM. Pharmacoeconomic
analysis of therapies for pediatric patients. Expert Rev
Pharmacoeconomics Outcomes Res 2004;4(5):365-9.
Raisch DW, Fudala PJ, Saxon AJ, Walsh R, Casadonte P, Ling W, Johnson B, Malkenecker U, Ordorica P, Williford WO, Sather MR. Pharmacists’ and technicians’ perceptions and attitudes towards dispensing buprenorphine/naloxone to opioid dependent patients. J Am Pharm Assoc 2005;45:23-32.
Graham AC, Raisch DW, Fye CL, Sather MR. Assessment of the impact of a patient clinical trials handbook among pharmacy students. Clin Ther 2005;27:238-45.
Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW. The Research on Adverse Drug Events and Reports (RADAR) Project. JAMA 2005;293:2131-2140.
Singh BN, Singh SN, Reda DJ, Tang CT, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis D Jr., Raisch DW, Ezekowitz MD, Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005.352:1861-72.
Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: A follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood 2005; 106:3343-7.
Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Pediatr Blood Cancer 2006;46(2):179-86.
Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47(1):175-81.
Holdsworth MT,
Raisch DW, Frost J. Acute
and delayed nausea and emesis control in pediatric oncology patients.
Cancer 2006;106(4):931-40.
Belknap SM, Kuzel TM, Yarnold PR, Slimack N, Lyons EA,
Raisch DW,
Bennett CL. Clinical features and correlates of gemcitabine-associated
lung injury: findings from the RADAR project. Cancer 2006;106(9):2051-7.
Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Jr, Lopez B, Raisch DW, Ezekowitz MD. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 2006;48(4):721-30.
Harris CL, Raisch DW, Abhyankar U, Marfatia S, Campbell HM, Sather MR. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs. Ann Pharmacother 2006;40(11):1924-31.
Gupchup GV, Abhyankar UL, Worley MM, Raisch DW, Marfatia AA, Namdar R. Relationships between Hispanic ethnicity and attitudes and beliefs toward herbal medicine use among older adults. Res Social Adm Pharm 2006;2(2):266-79.
Bennett CL, Angelotta C, Yarnold PR, Evens AM, Zonder JA, Raisch DW, Richardson P. Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA 2006;296(21):2558-60.
McKoy JM, AngelottaC, Bennett CL, Tallman MS, Wadleigh M, Evens AM, Kuzel TM, Trifilio SM, Raisch DW, Kell J, Deangelo DJ, Giles FJ. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project. Leuk Res 2007;31(5):599-604.
Jakiche R, Borrego ME,
Raisch DW, Gupchup
GV, Pai MA, Jakiche A. The Cost-Effectiveness of Two Strategies for
Vaccinating U.S. Veterans with Hepatitis C Virus Infection against
Hepatitis A and Hepatitis B Viruses. Am J Med Sci 2007;333(1):26-34.
Campbell HM,
Raisch DW, Sather MR, Warren SR, Segal AR. A comparison of
veteran and nonveteran motivations and reasons for participating in
clinical trials. Mil Med 2007;172(1):27-30.
Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, Zagory J, Trifilio S, Jakiche R, Palella F, Kahn A, Chandler K, Bennett CL. Systematic review of piperacillin-induced neutropenia. Drug Saf 2007;30(4):295-306.
Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med 2007;167(10):1041-9.
Campbell HM, Boardman KD, Dodd MA, Raisch DW. Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model. Ann Pharmacother 2007;41:1101-10.
Holdsworth MT, Fichtl RE, Raisch DW, Hewryk A, Behta M, Mendez-Rico E, Wong CL, Cohen J, Bostwick S. Greenwald BM. Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients. Pediatrics 2007; 120:1058-66.
Bennett CL, Kim B, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy M, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, De Masi D, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol 2007;12: 1138-43.
Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KW, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M . Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008; 299:914-924(doi:10.1001/jama.299.8.914).
Campbell HM, Raisch DW, Sather MR, Segal AR, Warren SR, Naik R. Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation. IRB: Ethics and Human Research 2008; 30(1):6-14.
Holodniy M,. Penzak SR, Straight TM, Davey RT, Lee KK, Goetz MB, Raisch DW, Cunningham F, Lin ET, Olivo M, Deyton LR. Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother. 2008;52:3013-21.
McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, Casadevall N, Bennett CL. Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion 2008;48:1754-62.
Shah BM, Gupchup GV, Borrego ME, Raisch DW, Knapp KK. Depressive symptoms in patients with type 2 diabetes mellitus in the ambulatory care setting: opportunities to improve outcomes in the course of routine care. J Am Pharm Assoc 2008;48:737-43.
Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol 2008;9:1166-72.
McKoy JM. Bennett CL, Scheetz MH, Differding V, Chandler KL, Scarsi KK, Yarnold PR, Sutton S, Palella F, Johnson S, Obadina E, Raisch DW, Parada JP. Hepatotoxicity Associated with Long- versus Short-Course HIV-Prophylactic Nevirapine Use: A Systematic Review and Meta-Analysis from the Research on Adverse Drug events And Reports (RADAR) Project. Drug Saf 2009;32:147-58.
Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL,Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL.. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl 2009:S20-4.
Kind P, Lafata JE, Matuszewski K, Raisch DW. The use of QALYs in clinical and patient decision-making: issues and prospects. Value Health 2009;12 Suppl 1:S27-30.
Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL. Progressive multifocal leukoencephalopathy following rituximab therapy in HIV negative patients: a report of 57 cases from the Research on Adverse Drug Event and Reports (RADAR) project. Blood 2009.
Raisch DW, Straight TM, Holodiny M. Thrombocytopenia from oseltamivir and probenecid: a case report plus Medwatch data summary and literature review. Pharmacotherapy 2009.
Mike R. Sather, PhD, FASHP
Sather MR, Boehm PE, Sleight SM. Review of Antiarrhythmic Drugs. Hosp Pharm. 1970; 5(Sep):3-20.
Sather MR. The Case for Clinical Pharmacy. NODAK Pharmacist. 1970; 9(Dec):13-7.
Sather MR, Sleight SM. Locally Produced Audio-visual Aids Can Improve Inservice Programs. Hosp Top. 1971; 49(Feb):57-9.
Sather MR. A Review of Antitubercular Drugs. Hosp Pharm. 1971; 6(Nov):7-19.
Sather MR. Education for the Clinical Role. NODAK Pharmacist. 1972; 11(Feb):25-30.
Sather MR. Clinical Pharmacy, Parts I, II, III, Ad Lib, College of Pharmacy (NDSU), March, April, May, 1972.
Sather MR, Weber CE Jr, George J, Beilman AA, Rasplica LF, Sweeney T. Educating Patients on a Spinal Cord Injury Unit for Self-medication. Hosp Pharm. 1976; 11(Jan):14-21.
Weber CE Jr, Sather MR. Discharge Medication Counseling. Hosp Top. 1976; 54(Nov/Dec):39-42.
Sather MR, Weber CE Jr, George J. Pressure Sores and the Spinal Cord Injury Patient. Drug Intell Clin Pharm. 1977; 11(Mar):154-69.
Weber CE Jr, Sather MR, Mace DL. Improving Patient Compliance Through Use of Single Daily Dosages. Hosp Pharm. 1977; 12 (Oct):508-10.
Sather MR, Weber CE Jr, Preston JD, Lyman GH, Sleight SM. Cancer Chemotherapeutic Agents: Handbook of Clinical Data. Boston, MA: G.K. Hall and Co.; 1978.
Sather MR. Investigative New Drugs - The IND and Proposed Federal Regulations on Clinical Investigations, Proceedings of the Second National VA Cooperative Studies Program Symposium, Chicago, IL, September 21-22, 1978. Academic Affairs and Medical Research Service, Veterans Administration Central Office, Washington, DC.
Scrivens JJ, Weber CE Jr, Sather MR, Geck WE. Filling and Refilling Practices with Diazepam and Methyldopa. Hospital Formulary. 1979; 14(Sep):830-8.
Preston JD, Lyman GH, Weber CE Jr, Sather MR, Sleight SM. Cancer Chemotherapeutic Agents: Handbook of Clinical Data. 2nd ed. Boston, MA: G.K. Hall and Co.; 1982.
Veterans Administration Pharmacy Service Study Group (Sather MR, Smith MC, Alexander MR, Weber CE Jr, Bowlin TH, May CN). Variable Cost Per Dose of Preparing and Administering Small-volume Cephalosporin Admixtures. Am J Hosp Pharm. 1984; 41(Dec):2624-34.
Sather MR, Weber CE Jr. Letter to Editor: Reducing the Costs of Cephalosporin Therapy. Am J Hosp Pharm. 1985; 42(Jul):1516-7.
Weber CE Jr, Sather MR, Smith MC. Cephalosporin Use in VA Medical Centers. VA Practitioner. 1986; 3(June):43-50.
Haakenson CM, Fye CL, Sather MR, Toussaint DJ. The Investigator-Sponsored IND in Clinical Trials. Controlled Clin Trials. 1987; 8:101-9.
Deykin D, Gold J, Sather M. The Cooperative Concept: Research on a Grand Scale. VA Practitioner. 1987; 4(Jun):95-104.
Fye CL, Haakenson CM, Sather MR, Day PL, Colling CL. IND Manual for Sponsor -Investigators, Clin Res Prac and Drug Reg Affairs. 1989; 7(2):69-116.
Sather MR, Haakenson CM, Fye CL, Buchanan SL, Colling CL, Day PL. Guidelines for a Sponsor - Investigator IDE (Investigational Device Exemption). Clin Res Prac and Drug Reg Affairs. 1989; 7(3):117-83.
Dorus W, Ostrow DG, Anton R, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malker Neker U, Willenbring M, Fiscella R, Sather MR. Lithium Treatment of Depressed and Nondepressed Alcoholics, JAMA. 1989; 262 (Sept):1646-52.
The Digitalis Investigation Group. Rationale, Design, Implementation and Baseline Characteristics of Patients in the DIG Trial: A Large, Simple Long-term Trial to Evaluate the Effect of Digitalis on Mortality in Heart Failure. Controlled Clin Trials. 1996; 17:76-97.
Haakenson C, Akiyama T, Hallstrom A, Sather MR. Masking Drug Treatments in the Cardiac Arrhythmia Pilot Study (CAPS). Controlled Clin Trials. 1996; 17:294-303.
The Digitalis Investigation Group. The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure. NEJM. 1997; 336:525-33.
Jones MS, Raisch DW, Garnand D, Sather MR. Use of a Remote Computerized System for Study Documentation in Clinical Trials. Drug Information Journal. 1998; 32:1153-63.
Henderson, WG, Lavori, PW, Peduzzi, P, Collins, JF, Sather, MR, Feussner, JR. Cooperative studies program, US Department of Veterans Affairs. In: Biostatistics in Clinical Trials, eds. Carol K. Redman and Theodore Colton. New York, John Wiley & Sons, 2001, pp 99-115.
Raisch DW, Troutman WG, Sather MR, Fudala PJ. Variability in the assessment of adverse events in a multicenter clinical trial. Clin Ther. 2001; 23:2011-20.
Raisch DW, Fye CL, Boardman KD,
Sather MR. Opioid dependence treatment including buprenorphine/naloxone. Ann
Pharmacother. 2002; 36: 312-21.
Collins JF, Sather MR. Regulatory issues for clinical trials.
Epidemiologic Reviews. 2002; 24:59-66.
Sather MR, Raisch DW, Haakenson CM, Buckelew JM, Feussner JR. Promoting good clinical practice in the conduct of clinical trials: Expanding the Department of Veterans Affairs Cooperative Studies Program. Controlled Clin Trials. 2003; 24:1-15.
Fye CL, Gagne WH, Raisch DW, Jones MS, Sather MR, Buchanan SL, Chacon FR, Garg R, Yusuf S, Williford WO. The role of the pharmacy coordinating center in the DIG trial. Controlled Clin Trials. 2003; 24: 289S-297S.
Henderson WG, Lavori PL, Peduzzi PN, Collins JF, Sather MR, Feussner JR. Cooperative Studies Program, US Department of Veterans Affairs. In: Encyclopedia of Biostatistics, P Armitage, T Colton, Eds. New York, John Wiley & Sons, Ltd., 1180-1196, 2005.
Graham AC, Raisch DW, Fye CL, Sather MR. Assessment of the impact of a patient clinical trials handbook among pharmacy students. Clin Ther 2005; 27:238-45.
Raisch DW, Fudala PJ, Saxon AJ, Walsh R, Casadonte P, Ling W, Johnson BA, Malkerneker U, Ordorica P, Williford WO, and Sather MR. Pharmacists’ and technicians’ perceptions and attitudes toward dispensing buprenorphine/naloxone to patients with opioid dependence. J Am Pharm Assoc 2005; 45:23-32
Morgan TR, et al. Colchicine treatment of alcoholic cirrhosis: A randomized, placebo-controlled clinical trial of patient survival. Gastroenterology 2005, 128:882-890.
Harris CL, Raisch DW, Abhyankar U, Marfatia S, Campbell HM, Sather MR. GI risk factors and use of GI protective agents among patients receiving nonsteroidal anti-inflammatory drugs. Ann Pharmacother 2006; 40.
Elkashef A,. Fudala PJ, Gorgon L, Li S-H, Kahn R, Chiang N, Vocci F, Collins J, Jones K, Boardman K, Sather M. Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence. Drug Alcohol Dependence 2006; 85:191-197.
Campbell HM, Raisch DW, Sather MR, Warren SR, Segal AR. A comparison of veteran and nonveteran motivations and reasons for participating in clinical trials. Military Medicine 2007; 172:27-30.
Naik RK, Borrego ME, Gupchup GV, Dodd M, Sather MR. Pharmacy students’ knowledge, attitudes, and evaluation of direct-to-consumer advertising. Am J Pharm Ed 2007; 71 (5):1-10.
Campbell HM, Raisch DW, Sather MR, Segal AR, Warren SR, Naik R. Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation. IRB: Ethics & Human Research, January-February 2008; 30(1): 6-14.
Student Publications & Presentations
Vishal Bali
Published Abstract
Bali, V. & Khan, N. (2009). Association between level of physical activity at work and prevalence of arthritis among working population. Value in Health, 12(3), Pg-A65.
Presentations
Bali, V. & Khan, N. (April, 2009). Association between level of physical
activity at work and prevalence of arthritis among working population. Paper
presented at 2nd Annual Graduate and Professional Research and Creative
Expression Symposium, UNM, Albuquerque, New Mexico.
Bali, V. & Khan, N. (January, 2009). Association between level of physical activity at work and prevalence of arthritis among working population. Paper presented at the College of Pharmacy Annual Research Retreat, Albuquerque, New Mexico.
Bali, V. Udupa, N. & Sachdeva, A. (November, 2005). Bio-generics: an opportunity or a challenge for Indian pharmaceutical industry: A survey. Paper presented at the 58th Indian Pharmaceutical Congress. Hyderabad, India.
Bali, V. Udupa, N. & Rao, J. V. (December, 2006). Generic business trends: Indian perspective. Presented at the 57th Indian Pharmaceutical congress. Mumbai, India.
Heather M. Campbell, PharmD
Peer-Reviewed Publications
Harris CL, Raisch DW, Abhyankar U, Marfatia S, Campbell HM, Sather MR. Assessment of the risk of gastrointestinal events among veterans affairs’ patients receiving nonsteroidal anti-inflammatory agents. Ann Pharmacother 2006; 40:1924-1931.
Campbell HM, Raisch DW, Sather MR, Warren SR, Segal A. Reasons for participating in clinical trials: a comparison between veterans and nonveterans. Mil Med 2007;172(1):27-30.
Campbell HM, Boardman KD, Dodd MA, Raisch DW. Pharmaceoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model. Ann Pharmacother 2007;41:1101-1110.
Campbell HM, Raisch DW, Sather MR, Segal AR, Warren SR. Impact of a clinical trials information booklet on patient knowledge, perceptions, and likelihood of participation. IRB 2008;30(1):6-14.
Editorials, Letters, and Reviews
Raisch DW, Holdsworth MT, Marshik PL, Campbell HM. Pharmacoeconomic analysis of therapies for pediatric patients. Expert Rev Pharmacoeconomics Outcomes Res 2004;4(5):483-7.
Yaffe K, Campbell H. Student corner: student interest survey results are in. ISPOR Connections 2006;12(1):12.
Campbell H, Wilke C, Lee SP. ISPOR Student corner: looking back and moving forward. ISPOR Connections 2008;14(2):15.
Peer-reviewed abstracts
Raisch DW, Harris CL, Netravali SS, Campbell H. Relationships between age, number of prescriptions, and co-morbidities among VA patients. Value Health 2004;7(6):668.
Campbell HM, Raisch DW, Ling W. Quality-adjusted life years gained with buprenorphine treatment for opiate addiction. Value Health 2005;8(3):385.'
Campbell HM, Raisch DW. Pharmacoeconomic analysis of fondaparinux versus enoxaparin for prevention of DVT after major orthopedic surgery. JAPhA 2006; 46(2):271.
Campbell HM, Boardman KD, Dodd MA, Raisch DW. Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in Type II diabetics. Value Health 2006; 9(3):A33.
Raisch DW, Campbell HM, Taylor Z. Relationships between venous thromboembolic (VTE) prophylactic treatments and VTE complications or thrombocytopenia and among veterans receiving total hip replacements. Value Health 2007;10(3):A38.
Campbell HM, Khan N, Raisch DW. Relationship between eating healthy foods and regular exercise and physical health, mental health, and health status in type 2 diabetics. Value Health 2007;10(3):A68.
Jakiche R, Campbell HM, Raisch DW, Taylor Z. The association between concomitant medications use and thromboembolic complications in elderly veterans undergoing major orthopedic surgery. Value Health 2007;10(3):A153.
Campbell HM, Raisch DW, Taylor Z. Cost of complications associated with total knee replacement and total hip replacement. Value Health 2007;10(3):A183.
Raisch DW, Campbell HM, Taylor ZW. Cost-effectiveness analysis of thromboprophylactic strategies after hip fracture repair. Value Health 2007;10(6):A413.
Campbell HM, Raisch DW, Taylor Z, Khan N. Cost-effectiveness analysis of thromboprophylactic strategies after major orthopedic surgery (MOS) in Veterans Affairs (VA) patients. JAPhA 2008;48(2):273.
Campbell HM, Raisch DW, Taylor Z, Khan N, Becker T. Cost-effectiveness analysis of thromboprophylactic strategies over 1 year after total knee replacement in veteran patients. Value Health 2008;11(3):A242.
Raisch DW, Campbell HM, Khan N, Taylor Z, Becker T. Cost-effectiveness analysis of thromboprophylactic strategies over 1 year after total hip replacement in veteran patients. Value Health 2008; 11(3):A242.
Becker T, Campbell HM. Daily alcohol consumption and race/ethnicity: their relationship to stroke or coronary artery disease in the US adult population. Value Health 2009;
Raisch DW, Campbell HM. A National Study Comparing the Cost of Illness of Gout Versus Difficult to Treat Gout in the Veterans Affairs Healthcare System. Value Health 2009;
Rupali Naik
Naik R, Borrego ME, Gupchup GV, Dodd M, Sather MR. Pharmacy students’ knowledge, attitudes and evaluation of direct-to-consumer advertising. AJPE. 2007; 71(5): Article 86.
Borrego ME, Short JK, House NA, Gupchup GV, Naik R, Cuellar D. New Mexico pharmacists’ knowledge, attitudes and beliefs toward prescribing oral emergency contraceptive products. JAPhA. 2006; 46:33–43.
Campbell HM, Raisch DW, Sather MR, Segal AR, Warren SR, Naik R. Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation. IRB Ethics and Human Research. 2008; 30(1): 6-14.
Naik R, Borrego M, Gupchup G, D’Angio R, Sabrsula S. Comparison of adherence to anti-hypertensives in a managed care population. Abstract published in Value in Health. 2004; 7(3):231.
Presentations
Naik R, Borrego M, Gupchup G, Dodd M, Sather M. Pharmacy students’ knowledge, attitudes and evaluation of direct-to-consumer advertising. Presented at the American Association of Colleges of Pharmacy Annual Meeting, San Diego, CA, July 8-12, 2006.
Naik R, Borrego M, Gupchup G, D’Angio R, Sabrsula S. Comparison of adherence to anti-hypertensives in a managed care population. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 9th Annual International Meeting, Arlington, VA, May 16-19, 2004.
Borrego ME, Short JK, House NA, Gupchup GV, Naik R, Cuellar D. New Mexico pharmacists’ knowledge, attitudes and beliefs toward prescribing oral emergency contraceptive products. American Pharmacists Association Annual Meeting, Orlando, Fla, April 1-5, 2005.
Robert Ringer, PharmD
Montgomery B, Lavori P, Garzotto M, Lee K, Brophy M, Thaneemit-Chen S, Kelly W, Basler J, Ringer R, Yu W, Whittemore A, Lin DW. Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer. Urology. 2008 Sep;72(3):474-80. Epub 2008 Apr 14. Review.
The
University of New Mexico’s Doctor of Pharmacy program is
accredited by the Accreditation Council for Pharmacy Education,
20 North Clark Street, Suite 2500, Chicago, IL 60602-5109, TEL
(312) 664-3575 , FAX (312) 664-4652,
URL
http://www.acpe-accredit.org/
01/30/2013 09:41:30 AM -0700.